|
Volumn 143, Issue 3, 2005, Pages
|
How should clinicians interpret results reflecting the effect of an intervention on composite endpoints: should I dump this lump?
a a a a a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
BIOASSAY;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
EDITORIAL;
EVIDENCE BASED MEDICINE;
FEMALE;
HUMAN;
METHODOLOGY;
PREGNANCY;
PREGNANCY DIABETES MELLITUS;
PREGNANCY OUTCOME;
RANDOMIZED CONTROLLED TRIAL;
STANDARD;
TREATMENT OUTCOME;
DIABETES, GESTATIONAL;
ENDPOINT DETERMINATION;
EVIDENCE-BASED MEDICINE;
FEMALE;
HUMANS;
PREGNANCY;
PREGNANCY OUTCOME;
RANDOMIZED CONTROLLED TRIALS;
TREATMENT OUTCOME;
|
EID: 32944459943
PISSN: 10568751
EISSN: None
Source Type: Journal
DOI: None Document Type: Editorial |
Times cited : (20)
|
References (0)
|